Stock Events

Stock Events

Spyre Therapeutics (3920.F) Q4 2024 Earnings

3920.F
Nov 7Confirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-3.75
-2.72
-1.7
-0.67

Details

Expected EPS
-0.76317573473
Actual EPS
-1.2591016000000002
Surprise EPS
-0.5
Surprise Percent
-64.98%

Description

⁨Spyre Therapeutics⁩ (⁦3920.F⁩) has reported earnings of ⁦-1.2591016000000002⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts